Marsh announces insurance facilities for data centre construction in Europe and the UK
Marsh, an insurance broker and risk advisor under Marsh McLennan, has launched Nimbus, an insurance facility aimed at building large data centres in the UK and Europe.
The facility is supported by a panel of Lloyd and Company Market in London and Europe.
It combines all risks of traditional construction, delays in starting up, property damage and business disruption coverage.
Nimbus offers up to 1 billion euros in all risk coverage for construction and up to 350 million euros due to delays in launch.
The launch coincides with a surge in data center construction projects in the region. Technology companies are competing to meet the growing demand for improved processing and storage capabilities.
The facility aims to provide clients with access to specialized coverage to enable more efficient management of data center construction projects.
“We’re committed to providing a range of services to our customers,” said Kelly Looney, CEO of Infrastructure & Surety, Marsh Specialty UK Construction. “The data center will rapidly become the fourth utility and the engine room of the global economy. Given the important role it plays in telecommunications, computer systems and data storage, it is essential that construction be completed within time and budget.
“Marsh is committed to enabling the technology sector to meet the growing demand for data center infrastructure. Nimbus provides project-specific coverage for clients through a streamlined process that encourages the delivery of data center construction projects and ensures a seamless transition of operational readiness.”
This announcement follows Marsh’s recent launch Data Center Insurance and Risk Management Services Introduction to Cybershore Bermudaexcessive cyber insurance facilities offering coverage up to $30 million.
“Marsh announces insurance facilities for the construction of data centres in Europe and the UK” was originally created and published by Life Insurance Internationala brand owned by GlobalData.
The information on this site is contained in good faith for general information purposes only. It is not intended to be the advice you should resort to, and we will not give any representations, warranties or warranties, whether express or implied regarding its accuracy or completeness. You should seek expert or expert advice before taking or refraining from taking any medication based on the content on our site.